February: covid-bloodclot, News and features

The risk of blood clots after COVID-19 vaccinations is very low finds a new study of 46-million adults in England. The research, which involved University of Bristol academics, showed that people vaccinated with Oxford-AstraZeneca or Pfizer-BioNTech had a lower risk of all venous clots (such as deep vein thrombosis and pulmonary embolism) and all arterial clots (such as strokes and heart attacks), particularly in people over 70 years.

Covid-19 vaccines seem to cut the risk of heart attacks and strokes

Covid: Blood clot risk higher for six months after having virus - BBC News

Vein & Vascular Treatment, Vein and Vascular Care Clinic

BBC presenter died from rare AstraZeneca blood clot, coroner concludes

COVID-19 diagnosis by routine blood tests using machine learning

Researchers claim mystery of rare blood clots tied to COVID-19 vaccines solved, but experts urge caution

Kawasaki-like Inflammatory Disease Affects Children With COVID-19

What do you do if you think you have VITT? What we know of the rare clotting disorder

Covid Creates Higher Risk for Blood Clots Than Vaccines Do - The New York Times

COVID: Blood clot risks still higher a year after infection, study says

Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England - Research and Practice in Thrombosis and

COVID-19 vaccines available at McChord Airman's Clinic > Team McChord > Article Display

February: covid-bloodclot, News and features

Bivalent COVID Vaccines Reduce Thromboembolic Events

Risk of Venous Thromboembolism after COVID-19 Low in Non-Hospitalized Patients